BIOINFRA Life Science Inc. announced a private placement of 1st series bearer's rights guarantee detachable convertible debentures for gross proceeds of KRW 4,000,000,000 on December 13, 2019. The transaction will include participation from Hizeasset Investment Co., Ltd. The bonds will be issued at 0% coupon rate, 4% yield to maturity rate, and will mature on December 18, 2024. The bonds can be 100% converted into 727,272 common shares for 4,72% stake in the company at a fixed conversion price of KRW 5,500 per share. The conversion period is from December 18, 2020 to November 18, 2024. The transaction has been approved by the board of directors of the company. The subscription date and the payment date is December 18, 2019.